Skip to content

The effect of alphalipoic acid in nausea of ??pregnancy

Comparing the effect of alipoic acid with vitamin B6 in the treatment of pregnancy nausea and vomiting

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231226060527N1
Enrollment
80
Registered
2024-10-01
Start date
2024-07-06
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Nausea and Vomiting. Vomiting of pregnancy, unspecified

Interventions

Intervention 1: Intervention group: vitamin B6 group (recipient of vitamin B6 tablets with a dose of 25 mg orally 3 times a day for one week). Intervention 2: Intervention group: Alpha-lipoic acid gro

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Gestational age (7 to 14 weeks) Symptoms of mild to moderate Nausea and Vomiting during Pregnancy with a score of 3 to 12 in the The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) Questionnaire

Exclusion criteria

Exclusion criteria: Multiple births PO intolerance Gestational age below 7 weeks and above 14 weeks BMI above 35 Taking Anti-vomiting and Anti-nausea Drugs (including Metoclopramide, Ondansetron, Dimenhydranate, etc.) within 48 hours before the visit Mothers who smoke or use Narcotics Abnormal pregnancy (molar pregnancy or its history, pregnancy with anomalous or dead fetus, ectopic pregnancy) Having severe mental disorders Other Pathologies that cause Nausea and Vomiting in Pregnancy: Gastroenteritis, Gastroparesis, Intestinal obstruction, Bile duct disease, Pancreatitis, Hepatitis, Gastric ulcer, Appendicitis, Pyelonephritis, Ovarian torsion, Urinary tract Stones, Diabetic Ketoacidosis, Patients with previous history Diabetes, uncontrolled gestational diabetes, Blood pressure, Liver dysfunction, Hyperthyroidism, Hyperparathyroidism, Migraine, false brain tumor, Vestibular diseases

Design outcomes

Primary

MeasureTime frame
The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) Questionnaire: the degree of discomfort or Nausea, the number of times of vomiting, the amount of burping in the last 12 hours. Timepoint: At the beginning of the study, 48 hours later, one week later. Method of measurement: The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShina Karimi

Sanandaj University of Medical Sciences

Sh.Karimi.Gyn@Gmail.com+98 87 3356 0595

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026